Dr. Douglas Weber is a Professor of Mechanical Engineering and Neuroscience at Carnegie Mellon University (CMU). He recently completed a 4-year term as a Program Manager in the Biological Technologies Office (BTO) at the Defense Advanced Research Projects Agency (DARPA) in Arlington, Virginia, where he created and managed a portfolio of neurotechnology programs, including DARPA’s Hand Proprioception and Touch Interfaces (HAPTIX), Electrical Prescriptions (ElectRx), and Targeted Neuroplasticity Training (TNT) programs.

Dr. Weber directs the Neuro-Mechatronics Lab at CMU, which pursues fundamental research aimed at understanding the neural basis for sensory perception, motor control, and cognition with an eye toward developing human-machine interface technologies for measuring and enhancing human performance. Applications include implantable brain-computer interfaces for sensing and controlling robotic and assistive technologies, wearable bioelectronic sensors for controlling robotic prostheses and exoskeletons, medical diagnostics and monitoring, and closed-loop control of neurostimulation to treat neurological disorders.

Dr. Weber is an elected fellow of the American Institute for Medical and Biological Engineering (AIMBE), a Senior Member of the Institute of Electrical and Electronics Engineers (IEEE), a member of the Society for Neuroscience and the American Physiological Society.  He holds 12 issued patents and is a co-founder of Reach Neuro, Inc., a Pittsburgh-based startup that is developing a novel neuromodulation therapy for stroke rehabilitation.

Dr. Weber’s current list of research interests includes:  Bioengineering; neural coding; neuroprosthetics; functional electrical stimulation; and, neuromuscular control and rehabilitation.

View a list of Dr. Weber’s publications here.